1996
DOI: 10.1159/000189157
|View full text |Cite
|
Sign up to set email alerts
|

Hypophosphatemia in End Stage Renal Disease

Abstract: A case of hypophosphatemia in a 55-year-old black female on maintenance hemodialysis is described. She developed multiple bone fractures and congestive heart failure during her 10-year period on hemodialysis. Iliac crest bone biopsy revealed osteomalacia with absent aluminum stores. Management was difficult due to her noncompliance secondary to severe depression. Though osteomalacia and cardiomyopathy due to hypophosphatemia are described in patients with end stage renal disease on dialysis, it is an uncommon … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(2 citation statements)
references
References 13 publications
(13 reference statements)
0
2
0
Order By: Relevance
“… SGLT2 inhibitors can cause euglycemic DKA as a direct effect of their mechanisms of action, noninsulin-dependent glucose clearance, hyperglucagonemia, and volume depletion. The recovery phase of DKA may be associated with severe hypophosphatemia requiring timely and appropriate repletion of phosphate ( 9 , 10 ). Euglycemic DKA may be overlooked in the setting of moderately elevated blood glucose, which can lead to misdiagnosis, delayed treatment, and worsening metabolic derangements.…”
Section: Clinical Pearlsmentioning
confidence: 99%
See 1 more Smart Citation
“… SGLT2 inhibitors can cause euglycemic DKA as a direct effect of their mechanisms of action, noninsulin-dependent glucose clearance, hyperglucagonemia, and volume depletion. The recovery phase of DKA may be associated with severe hypophosphatemia requiring timely and appropriate repletion of phosphate ( 9 , 10 ). Euglycemic DKA may be overlooked in the setting of moderately elevated blood glucose, which can lead to misdiagnosis, delayed treatment, and worsening metabolic derangements.…”
Section: Clinical Pearlsmentioning
confidence: 99%
“…The recovery phase of DKA may be associated with severe hypophosphatemia requiring timely and appropriate repletion of phosphate ( 9 , 10 ).…”
Section: Clinical Pearlsmentioning
confidence: 99%